2,5-Dimethyl-Celecoxib Inhibits Cell Cycle Progression and Induces Apoptosis in Human Leukemia Cells-Reference-Cited by-同舟云学术

2,5-Dimethyl-Celecoxib Inhibits Cell Cycle Progression and Induces Apoptosis in Human Leukemia Cells

Published:2015-09-01 Issue:2 Volume:355 Page:308-328
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Sobolewski Cyril,Rhim Jiyun,Legrand Noémie,Muller Florian,Cerella Claudia,Mack Fabienne,Chateauvieux Sébastien,Kim Jeoung-Gyun,Yoon Ah-Young,Kim Kyu-Won,Dicato Mario,Diederich Marc^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference81 articles.

1. Mcl-1 is a potential therapeutic target in multiple types of cancer

2. Cyclooxygenase Inhibition and Cardiovascular Risk

3. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1

4. Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the treatment of non–small cell lung cancer

5. Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells;Bioorganic & Medicinal Chemistry;2022-12

2. Recent advances in the development of celecoxib analogs as anticancer agents: A review;Archiv der Pharmazie;2022-08-22

3. Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study;Frontiers in Oncology;2021-09-10

4. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib;Biomolecules;2021-07-16

5. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis;Journal of Molecular Neuroscience;2021-01-05